288 related articles for article (PubMed ID: 18835678)
1. Measuring the quality of substance use disorder treatment: evaluating the validity of the Department of Veterans Affairs continuity of care performance measure.
Harris AH; Humphreys K; Bowe T; Kivlahan DR; Finney JW
J Subst Abuse Treat; 2009 Apr; 36(3):294-305. PubMed ID: 18835678
[TBL] [Abstract][Full Text] [Related]
2. Veterans Affairs facility performance on Washington Circle indicators and casemix-adjusted effectiveness.
Harris AH; Humphreys K; Finney JW
J Subst Abuse Treat; 2007 Dec; 33(4):333-9. PubMed ID: 17400416
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial of onsite versus referral primary medical care for veterans in addictions treatment.
Saxon AJ; Malte CA; Sloan KL; Baer JS; Calsyn DA; Nichol P; Chapko MK; Kivlahan DR
Med Care; 2006 Apr; 44(4):334-42. PubMed ID: 16565634
[TBL] [Abstract][Full Text] [Related]
4. Treatment setting and baseline substance use severity interact to predict patients' outcomes.
Tiet QQ; Ilgen MA; Byrnes HF; Harris AH; Finney JW
Addiction; 2007 Mar; 102(3):432-40. PubMed ID: 17298651
[TBL] [Abstract][Full Text] [Related]
5. Performance monitoring of substance use disorder interventions in the Veterans Health Administration.
Humphreys K; Harris AH; Kivlahan DR
Am J Drug Alcohol Abuse; 2009; 35(3):123-7. PubMed ID: 19462294
[TBL] [Abstract][Full Text] [Related]
6. Developing and validating process measures of health care quality: an application to alcohol use disorder treatment.
Harris AH; Kivlahan DR; Bowe T; Finney JW; Humphreys K
Med Care; 2009 Dec; 47(12):1244-50. PubMed ID: 19786908
[TBL] [Abstract][Full Text] [Related]
7. Does case mix matter for substance abuse treatment? A comparison of observed and case mix-adjusted readmission rates for inpatient substance abuse treatment in the Department of Veterans Affairs.
Phibbs CS; Swindle RW; Recine B
Health Serv Res; 1997 Feb; 31(6):755-71. PubMed ID: 9018215
[TBL] [Abstract][Full Text] [Related]
8. Predictive Validity of Outpatient Follow-up After Detoxification as a Quality Measure.
Schmidt EM; Gupta S; Bowe T; Ellerbe LS; Phelps TE; Finney JW; Humphreys K; Trafton J; Vanneman ME; Harris AHS
J Addict Med; 2017; 11(3):205-210. PubMed ID: 28282324
[TBL] [Abstract][Full Text] [Related]
9. The association of persistent pain with out-patient addiction treatment outcomes and service utilization.
Caldeiro RM; Malte CA; Calsyn DA; Baer JS; Nichol P; Kivlahan DR; Saxon AJ
Addiction; 2008 Dec; 103(12):1996-2005. PubMed ID: 18855809
[TBL] [Abstract][Full Text] [Related]
10. A survey of PTSD screening and referral practices in VA addiction treatment programs.
Young HE; Rosen CS; Finney JW
J Subst Abuse Treat; 2005 Jun; 28(4):313-9. PubMed ID: 15925265
[TBL] [Abstract][Full Text] [Related]
11. An economic evaluation of inpatient residential treatment programs in the Department of Veterans Affairs.
Wagner TH; Chen S
Med Care Res Rev; 2005 Apr; 62(2):187-204. PubMed ID: 15750176
[TBL] [Abstract][Full Text] [Related]
12. Treatment staff's continuity of care practices, patients' engagement in continuing care, and abstinence following outpatient substance-use disorder treatment.
Schaefer JA; Harris AH; Cronkite RC; Turrubiartes P
J Stud Alcohol Drugs; 2008 Sep; 69(5):747-56. PubMed ID: 18781250
[TBL] [Abstract][Full Text] [Related]
13. Predictive validity of two process-of-care quality measures for residential substance use disorder treatment.
Harris AH; Gupta S; Bowe T; Ellerbe LS; Phelps TE; Rubinsky AD; Finney JW; Asch SM; Humphreys K; Trafton J
Addict Sci Clin Pract; 2015 Oct; 10():22. PubMed ID: 26520402
[TBL] [Abstract][Full Text] [Related]
14. Contract program for veterans with alcohol and drug dependence disorders--VA. Final rule.
Fed Regist; 1996 Nov; 61(215):56897. PubMed ID: 10172801
[TBL] [Abstract][Full Text] [Related]
15. Important aspects of end-of-life care among veterans: implications for measurement and quality improvement.
Casarett D; Pickard A; Amos Bailey F; Ritchie C; Furman C; Rosenfeld K; Shreve S; Shea JA
J Pain Symptom Manage; 2008 Feb; 35(2):115-25. PubMed ID: 18053680
[TBL] [Abstract][Full Text] [Related]
16. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems.
Timko C; Dixon K; Moos RH
Ment Health Serv Res; 2005 Dec; 7(4):229-42. PubMed ID: 16320106
[TBL] [Abstract][Full Text] [Related]
17. Assessing spirituality/religiosity in the treatment environment: the Treatment Spirituality/Religiosity Scale.
Lillis J; Gifford E; Humphreys K; Moos R
J Subst Abuse Treat; 2008 Dec; 35(4):427-33. PubMed ID: 18424049
[TBL] [Abstract][Full Text] [Related]
18. The effect of assertive continuing care on continuing care linkage, adherence and abstinence following residential treatment for adolescents with substance use disorders.
Godley MD; Godley SH; Dennis ML; Funk RR; Passetti LL
Addiction; 2007 Jan; 102(1):81-93. PubMed ID: 17207126
[TBL] [Abstract][Full Text] [Related]
19. Predictive validity of a quality measure for intensive substance use disorder treatment.
Schmidt EM; Gupta S; Bowe T; Ellerbe LS; Phelps TE; Finney JW; Asch SM; Humphreys K; Trafton J; Vanneman M; Harris AHS
Subst Abus; 2017; 38(3):317-323. PubMed ID: 27435754
[TBL] [Abstract][Full Text] [Related]
20. End-of-treatment outcomes in cognitive-behavioral treatment and 12-step substance use treatment programs: do they differ and do they predict 1-year outcomes?
Johnson JE; Finney JW; Moos RH
J Subst Abuse Treat; 2006 Jul; 31(1):41-50. PubMed ID: 16814009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
